GlassScriptPhysician profile
Talha R Memon
NPI 1922410869
$4,535.13
in general payments reported to CMS, 2019-2025
16 companies · $616 in 2025
The $616 reported for 2025 was more than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
See the full distribution for Sleep Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $1,349 · 2021: $218 · 2022: $478 · 2023: $793 · 2024: $812 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624 · Education: $544 · Travel and Lodging: $52.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.64 |
| Education | $544.04 |
| Travel and Lodging | $52.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,416.88 | 2020-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,161.30 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $339.02 | 2021-2024 | Wakix |
| Arbor Pharmaceuticals, INC. | $105.43 | 2019-2022 | |
| Eisai INC. | $74.73 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $71.44 | 2023 | Quviviq |
| Resmed Corp | $68.85 | 2024-2025 | |
| Glaxosmithkline, LLC. | $63.32 | 2019 | |
| Noctrix Health, INC. | $61.24 | 2024-2025 | Nidra |
| Axsome Therapeutics, INC. | $44.85 | 2023 | Sunosi |
| Fisher & Paykel Healthcare INC | $42.65 | 2022-2024 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $23.88 | 2025 | Lumryz |
| Azurity Pharmaceuticals, INC. | $21.66 | 2025 | Horizant |
| Lilly USA, LLC | $17.37 | 2025 | Mounjaro, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $15.01 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $7.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talha Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.